Category: Press Releases

Bedford, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — Conagen, the Massachusetts-based biotechnology innovator, announced the successful development of antioxidant kaempferol produced by state-of-the-art, proprietary, precision fermentation. As a biotechnology company specializing in developing commercially valuable molecules for its partners and clients, Conagen’s kaempferol enables brands in nutrition, beauty, and personal care products to adopt a more natural position by formulating with clean and sustainable kaempferol.Recognized as one of nature’s most potent antioxidants, kaempferol is a flavonoid with health-promoting properties found in tea, fruits, and vegetables, especially rich in green leafy vegetables such as spinach and kale.

Rising consumer awareness towards chronic diseases such as cancer and diabetes drives the kaempferol market demand. The global kaempferol market may exceed $6.5 billion by 2025, according to a recent research report by Global Market Insights, Inc.

“We’re bringing to market a pure and natural kaempferol at affordable prices that were not possible or available until now,” said Casey Lippmeier, Ph.D. vice president of innovation at Conagen. “Conagen’s scalable, precision fermentation for producing flavonoids like kaempferol is more efficient and sustainable than what can be achieved with the chemically-synthesized or botanically-sourced molecule.”

Flavonoids are polyphenolic compounds commonly found in plants and are a significant part of the human diet. They are biosynthesized by plants and fungi as secondary metabolites and comprise a diverse group of phytonutrients.

Plants protect themselves and their fruits against biological intruders such as fungi and bacteria by using phenolic phytochemicals, including flavonoids. Accordingly, kaempferol provides powerful anti-microbial, anti-inflammatory, and immune system benefits to humans.

Dietary kaempferol in multiple studies has demonstrated a wide range of promising beneficial activities, primarily as an anti-inflammatory and antioxidant, for reducing the risk of chronic diseases, especially cancer.

Prolonged oxidative stress leads to premature aging and can trigger many degenerative diseases and cancer. Kaempferol’s powerful antioxidant property can help the body’s defense against free radicals that promote cancer development.

Conagen derived kaempferol from its molecular platform for flavonoid antioxidants, including the previously announced molecules: DHQ, also known as Taxifolin, p-coumaric acid, hydroxytyrosol, and rosmarinic acid. The development of natural kaempferol is good news for Conagen’s commercialization partner, Blue California, as kaempferol will expand its offerings of specialty ingredient solutions.

“This launch further demonstrates our talent for delivering innovative compounds which are ideal for dietary supplements and ‘clean-label’ ingredients for functional foods, beverages, and cosmetics,” said Lippmeier. “Our vision for promoting health and wellness is to continuously leverage our precision fermentation capabilities for high-quality phenolic and flavonoid phytonutrients, thus confirming our position as a leader in the development of strains and processes for making clean-label ingredients and nutraceuticals.”

Blue California has a long-standing partnership with biotechnology innovator Conagen. Conagen focuses on developing sustainable, nature-based ingredients that improve existing options in the market or represent completely novel ingredient solutions.

About Conagen

Conagen is a product-focused, synthetic biology R&D company with large-scale contract manufacturing capabilities. Our scientists and engineers use the latest synthetic biology tools to develop high-quality, sustainable, nature-based products by precision fermentation and enzymatic bioconversion. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. www.conagen.com

About Blue California

Blue California is a vertically integrated technology company providing innovative ingredient solutions to global partners. With more than 20 years of innovation success, our ingredients are used in commercial products and applications in nutrition, personal care, healthy aging and wellness, functional food and beverage, and beauty. www.bluecal-ingredients.com

Attachment

• kaempferol is found in Kale.

Ana Arakelian, Head of Public Relations and Communications
Conagen
+1.781.271.1588
ana.arakelian@conagen.com

OTTAWA, Ontario and CAMBRIDGE, United Kingdom, Jan. 04, 2022 (GLOBE NEWSWIRE) — Harris, a global vertical market software provider, has acquired the i2 intelligence analysis product portfolio of IBM, including the i2 Analyst’s Notebook, i2 Enterprise Insight Analysis (EIA) and i2 iBase platforms. The acquisition positions Harris to further deliver mission-critical applications for national defense, state & local law enforcement, maritime security as well as evidence management.

i2’s advanced analytics and intelligence analysis tools, such as the industry leading i2 Analyst’s Notebook, help analysts transform data into decisions in near-real-time, uncover hidden connections with visual displays, and turn overwhelming and disparate data—regardless of the source—into actionable intelligence.

The i2 product portfolio, i2 executives and their global teams will form a new Harris business unit, i2 Group, which will operate independently and autonomously. Jean Soucy, Harris Group President stated: “The acquisition of i2 is important to Harris because not only is it a proven business with an excellent international team of experts, but it also provides Harris with a feature-rich intelligence platform widely deployed by an influential customer base”, adding, “We look forward to working with our partners and customers to expand i2’s capabilities in this highly innovative space.”

“Resilience and collaboration have never been more critical for organizations as they confront the increasing complexity of intelligence analysis. We’re committed to addressing those needs by offering the most complete end-to-end intelligence analysis portfolio on the market” said Jamie Caffrey, Program Director at i2 Group. “The convergence of data and processes is transforming the industry. By integrating i2 into their existing networks, customers will be able to better leverage their data and will be empowered to unlock valuable insights that can translate into business success.”

As part of publicly traded Constellation Software Inc. (TSX: CSU), Harris’ financial strength, software industry expertise, and public safety focus were important factors in finding a forever home to execute i2 Group’s long-term growth strategies.

Visit www.i2group.com to learn more about i2 solutions.

For further information contact:

Jean Soucy
Group President
Phone: +1 581-205-9821
Email: JSoucy@harriscomputer.com

Steve Hammond
Portfolio Leader
Phone: +44 787-486-2811
Email: SHammond@harriscomputer.com

About N. Harris Computer Corporation (Harris)

Harris acquires vertical market software businesses, manages them well, and builds them for the future. Through acquisitions, Harris has grown extensively from its roots in the utilities, local government, education, and healthcare verticals to operate over 170 businesses globally across more than 20 industries. We are a part of Constellation Software Inc. (TSX: CSU), one of the world’s most active acquirers of VMS businesses.

About Constellation Software Inc.
Constellation Software acquires, manages and builds vertical market software businesses.

New addition strengthens executive management team of Amsterdam based global network company

AMSTERDAM, The Netherlands, Jan. 04, 2022 (GLOBE NEWSWIRE) — Expereo, the world’s leading provider of Global Internet, Cloud Access Optimization, SASE, and SD-WAN services, has today announced the appointment of Ben Elms as Chief Revenue Officer. Elms’ s overarching brief is to lead the Sales and go-to-market transformation across all channels and drive the expansion and adoption of Expereo’s services globally.

Elms brings more than 20 years of operational expertise and leadership in the telecommunications industry. Most recently, he served as the Group Director (CEO) at Vodafone Global Enterprise, a division of Vodafone Group Plc, a leading international wireless and wireline operator. Whilst there, he was responsible for leading global team managing relationships with multinational customers around the globe. During his tenure, the business outperformed the market with strong EBITDA performance and delivered significant improvements in customer and employee satisfaction whilst driving a program of operational efficiencies.

With his strong market experience, customer track record, and breadth of international expertise, he is a significant hire for the company as it continues its global growth and development.

Commenting on the appointment Irwin Fouwels, CEO at Expereo, said,

“Ben exhibits all the trademarks of a great leader, a true team player with super-strong commercial acumen and operational experience whilst demonstrating a relentless focus on the needs of the customer. Over the last few years, we see enterprises becoming even more cloud and internet-centric. Expereo has established a global leadership position in the highly attractive global cloud and software-defined networking market. I am very excited to have Ben join our company to continue our global go-to-market transformation. I am looking forward to a great partnership to take Expereo to further heights.”

On joining the Expereo, Elms said:

“I am honored to be appointed as Expereo’s first Chief Revenue Officer and to lead the next phase of growth. Expereo is on an exciting journey and has developed a unique market leadership position. My immediate focus will be on serving our customers as we continue to invest and expand our market position and in building operational excellence in our go-to-market. I look forward to speaking and meeting with employees, customers, and partners and working with Irwin and the team to take the business forward in a market that has a huge opportunity.”

Elms’ appointment comes after a sustained period of acquisition and expansion for Expereo, which will continue into 2022. With Elms added to its executive management team, the business will look to further consolidate its position as a leading player in the market – delivering simplified global networks while delighting customers with the seamless delivery of complementary services from one trusted supplier

About Expereo
Expereo is the leading provider of managed network solutions, including Global internet connectivity, SD-WAN, SASE, and Cloud Access Optimization services. Expereo is the trusted partner of 30% of Fortune 500 companies and powers enterprise and government sites worldwide, helping to enhance every business’ productivity with flexible and optimal Internet performance. In Feb 2021, Vitruvian Partners international growth capital and buyout firm acquired a majority stakeholding in Expereo, alongside the leading European private equity firm Apax Partners SAS and company management.

LinkedIn | Twitter |

MEDIA CONTACT:
Sofia Pensado
Account Director
sofia@grammatikagency.com
+447540221914

NetSfere won a place on the £250m NHS SBS Patient/Citizen Communication & Engagement Solutions Framework through which all NHS organizations can access communication platforms

CHICAGO, Jan. 04, 2022 (GLOBE NEWSWIRE) — NetSfere, a global provider of next-generation secure and compliant messaging and mobility solutions, has been named an approved communication supplier on NHS Shared Business Service’s (NHS SBS) Patient/Citizen Communication & Engagement Solutions Framework, under which NHS organizations and the public sector in the UK can contract services.

Through the £250m framework designed to enhance interactions with patients and advance the digitization of the United Kingdom’s healthcare system, all NHS organizations have access to NetSfere’s portfolio of products.

The framework aims to provide a simple, effective, efficient, and compliant route to market for the supply of communication methods to engage with patients, citizens and the workforce across NHS organizations and wider public sector bodies.

“Helping healthcare organizations streamline communications in a secure and efficient method has been a primary focus of NetSfere,” said Franz Obermayer, NetSfere’s Vice President UK & Europe. “As part of the Patient/Citizen Communications & Engagement Solutions Framework, NetSfere’s platforms are available to support NHS organizations’ needs for digital tools on a massive scale as the healthcare system looks to improve clinical efficiency and safety to increase patient satisfaction and address concerns that arose from the pandemic.”

Providing NHS organizations multiple avenues to streamline internal and external communications, the NetSfere platform is the leading enterprise mobile messaging service that provides all preferred means of communication – text, video, and voice – all in one encrypted platform. With omnichannel and emergency alert capabilities, NetSfere’s portfolio offers the most holistic, secure, all-in-one communication solution on the market.

“The coronavirus pandemic has added to the complexity of patient appointments and waiting lists,” said Adam Nickerson, Senior Category Manager of Digital and IT at NHS Shared Business Services. “Our Patient/Citizen Communications & Engagement Solutions Framework is designed to respond to the need within the NHS for better pre- and post-appointment communications, to reduce the backlog of urgent appointments and improve the patient journey, pathway and care.”

Addressing the need for compliant and efficient internal communication methods, NetSfere Enterprise features solutions that empower employees with powerful, enterprise-class messaging technology, eliminating the need to use risky, consumer-grade messaging apps. Created with end-to-end encryption and full IT control, the platform is compliant with global regulations and provides enterprises with a private, highly secure, reliable centrally managed and controlled, cloud-based messaging service.

On the patient communication side, NetSfere Omnichannel enables digital customer engagement from a single platform with multi-channels to orchestrate the customer communication journey, including 1-way and 2-way SMS, MMS and RCS messaging, push notifications, voice, email, and social media messaging. The platform provides key benefits like intelligent routing and cost optimization, content management, number validation for increased open rates, full enterprise admin controls, rich analytics, and data archiving. The platform protects medical staff and patients with the highest level of security and meets all regulatory compliance standards including HIPAA, GDPR and PCI DSS.

NHS organizations can also implement NetSfere Lifeline through the framework. The solution allows enterprises to send high priority, critical messaging for targeted teams or an entire organization to disperse emergency information in an attention-grabbing manner. Messages can include text, images, or locations, ensuring that all essential information can be shared quickly in critical situations.

As one of the selected suppliers, NetSfere’s solutions were accepted across five lots: Digital (Online) Communication, Email, SMS, Workforce Communication, and All-in-One Solutions.
For more information on NetSfere’s portfolio of products, visit www.netsfere.com.

About NetSfere
NetSfere is a secure enterprise messaging service and platform from Infinite Convergence Solutions, Inc. NetSfere provides industry-leading security and message delivery capabilities, including global cloud-based service availability, device-to-device encryption, location-based features and administrative controls. The service is also offered in partnership with Deutsche Telekom GmbH, one of the world’s leading integrated telecommunications companies, and with NTT Ltd., a global information communications & technology service provider, to jointly offer NetSfere to its worldwide customers. The service leverages Infinite Convergence’s experience in delivering mobility solutions to tier 1 mobile operators globally and technology that supports more than 400 million subscribers and over a trillion messages on an annual basis. NetSfere is also compliant with global regulatory requirements, including GDPR, HIPAA, Sarbanes-Oxley, ISO 27001 and others. Infinite Convergence Solutions has offices in the United States, Germany, India and Singapore. For more information, visit www.netsfere.com.

About NHS Shared Business Services
NHS Shared Business Services (NHS SBS) was created in 2004 by the Department of Health and Social Care (DHSC) to deliver corporate services to the NHS. A unique joint venture with Sopra Steria, a European leader in digital services and software development, it makes life easier for NHS employees, patients and suppliers, and deliver value for money to the taxpayer.

Proud members of the NHS family, NHS SBS provides finance & accounting, procurement and workforce services to more than half the NHS in England. Sharing common values and unity of purpose with the rest of the NHS family, its solutions are underpinned by cutting-edge technologies and the teams’ expertise, in-depth understanding of the NHS, and commitment to service excellence.

Media Contact
Rachel Gunia
Uproar PR for NetSfere
312-878-4575 x246
rgunia@uproarpr.com